InvestorsHub Logo
Followers 20
Posts 5327
Boards Moderated 0
Alias Born 01/04/2012

Re: silvr_surfr post# 13829

Friday, 05/20/2022 6:03:41 AM

Friday, May 20, 2022 6:03:41 AM

Post# of 14862
Silvr, HH&R have a competent 2nd tier ranking Anti-Trust & Competition practice. and have the highest rank in mergers and acquisitions.

HH&R rankings

It is not like HH&R did not have competence to deal with the divestiture to appease the FTC.

William J. Kolasky is a partner in the Washington, DC, office of Hughes Hubbard & Reed. He has nearly 40 years of experience across the full range of antitrust litigation and counseling. William regularly represents clients in antitrust litigation before courts all over the country. He also represents clients in criminal and civil investigations before both the Antitrust Division of the Department of Justice and the Federal Trade Commission. He has secured antitrust clearance from the two agencies for more than 100 mergers and acquisitions, and has coordinated merger reviews in multiple jurisdictions around the world. He also regularly counsels clients about antitrust aspects of a wide variety of business arrangements, from joint ventures to distribution arrangements. In 2013, he received the Global Competition Review's Lifetime Achievement Award for his accomplishments in private practice, government service and antitrust scholarship.

William served as deputy assistant attorney general in the Antitrust Division of the US Department of Justice. While there, he was one of the architects of the International Competition Network, a network of over 100 competition authorities worldwide designed to promote greater international cooperation and convergence among those authorities. He has also taught antitrust law for over 10 years at American University's Washington College of Law.



William J. Kolasky

Looks like they are leaving nothing to chance. Or, they have conflict of interest, likely tied to Libigel.

If ANIP were to participate in a co-development deal regarding testosterone by a certain date, they would need their R&D team in place. Especially if Merck and/or AbbVie are involved, everything is time sensitive, given the LOE they are facing.

JMHO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News